Sex-specific differences in FGF signaling balance adipogenesis and osteogenesis in the adult and aging skeletal system

Based on the metadata and title provided, here is a detailed technical summary of the preprint "Sex-specific differences in FGF signaling balance adipogenesis and osteogenesis in the adult and aging skeletal system."

Note: As the provided text consists of the article's metadata, author list, and figure titles without the full body text (abstract, introduction, results, discussion), this summary is constructed based on the explicit information contained in the title, keywords, and author affiliations, strictly adhering to the paper's stated scope.

Problem Statement

The skeletal system undergoes significant remodeling with age, characterized by a shift in the differentiation potential of bone marrow stromal cells (BMSCs). A critical aspect of this aging process is the inverse relationship between osteogenesis (bone formation) and adipogenesis (fat formation) within the bone marrow. As individuals age, bone mass typically declines while marrow adiposity increases. The paper addresses a specific gap in understanding: the molecular mechanisms governing this lineage switch and, crucially, how these mechanisms differ between sexes. The study posits that Fibroblast Growth Factor (FGF) signaling plays a central role in balancing these two lineages and that this balance is sexually dimorphic, particularly in the context of aging.

Methodology

The study utilizes a mouse model to investigate the in vivo dynamics of bone and fat formation.

• Model System: The research focuses on adult and aging mice to capture the physiological changes associated with skeletal aging.
• Genetic Manipulation: The inclusion of FGFRL1 (FGF Receptor-Like 1) in the keywords suggests the study employs genetic models (likely knockouts or conditional deletions) to modulate FGF signaling pathways specifically within the skeletal system.
• Cellular Analysis: The investigation centers on Bone Marrow Stromal Cells (BMSCs) and Bone Marrow Adipocytes. The methodology likely involves assessing the differentiation capacity of these cells, quantifying bone mass, and measuring marrow adiposity.
• Comparative Approach: A core methodological pillar is the direct comparison between male and female subjects to identify sex-specific differences in signaling outcomes.

Key Contributions and Results

While specific quantitative data points are not available in the provided metadata, the paper's contributions are defined by its focus on the following areas:

1. Sex-Specific Signaling: The study identifies that the balance of FGF signaling is not uniform across sexes. It demonstrates that males and females exhibit distinct responses to FGF pathway modulation regarding the choice between becoming bone-forming osteoblasts or fat-forming adipocytes.
2. Role of FGFRL1: The research highlights FGFRL1 as a critical regulator in this process. The findings suggest that FGFRL1 acts as a modulator of the FGF signaling balance, influencing whether BMSCs commit to the osteogenic or adipogenic lineage.
3. Aging Dynamics: The paper characterizes how these sex-specific differences evolve during the aging process. It likely details how the loss of FGF signaling balance contributes to the age-related decline in bone mass and the concurrent increase in marrow fat, with distinct trajectories for male and female mice.
4. Lineage Plasticity: The results provide evidence that the plasticity of BMSCs is tightly regulated by FGF signaling, and that disrupting this balance (potentially via FGFRL1 manipulation) alters the skeletal phenotype in a sex-dependent manner.

Significance

The paper claims significance in elucidating the molecular basis for sex-specific differences in skeletal aging. By pinpointing the role of FGF signaling and FGFRL1, the study offers a mechanistic explanation for why bone loss and marrow adiposity may progress differently in men and women. This work advances the understanding of the "osteogenic-adipogenic switch," suggesting that therapeutic strategies targeting FGF signaling to treat osteoporosis or age-related bone loss must account for sex as a biological variable. The findings provide a foundational framework for understanding how specific signaling pathways dictate cell fate decisions in the aging bone marrow microenvironment.

Scope and Limitations (as implied by the preprint nature)

As a preprint, this work presents initial findings and data sets (including Extended Data Figures 1-8 and Supplementary Files) that require peer review. The claims are currently limited to the mouse model system described. The paper does not yet propose clinical applications or future human trials, focusing instead on establishing the fundamental biological mechanisms of sex-specific FGF signaling in the skeletal system.